193 related articles for article (PubMed ID: 12876487)
1. Differential expression of proliferation- and apoptosis-related markers in lentigo maligna and solar keratosis keratinocytes.
Feinmesser M; Tsabari C; Fichman S; Hodak E; Sulkes J; Okon E
Am J Dermatopathol; 2003 Aug; 25(4):300-7. PubMed ID: 12876487
[TBL] [Abstract][Full Text] [Related]
2. A quantitative immunohistochemical evaluation of lentigo maligna and pigmented solar keratosis.
Lane H; O'Loughlin S; Powell F; Magee H; Dervan PA
Am J Clin Pathol; 1993 Dec; 100(6):681-5. PubMed ID: 8249917
[TBL] [Abstract][Full Text] [Related]
3. S100A protein expression in the distinction between lentigo maligna and pigmented actinic keratosis.
Ribé A; McNutt NS
Am J Dermatopathol; 2003 Apr; 25(2):93-9. PubMed ID: 12652189
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry of pigmented actinic keratoses, actinic keratoses, melanomas in situ and solar lentigines with Melan-A.
Helm K; Findeis-Hosey J
J Cutan Pathol; 2008 Oct; 35(10):931-4. PubMed ID: 18494818
[TBL] [Abstract][Full Text] [Related]
5. Unstable solar lentigo: A defined separate entity.
Byrom L; Barksdale S; Weedon D; Muir J
Australas J Dermatol; 2016 Aug; 57(3):229-34. PubMed ID: 26832231
[TBL] [Abstract][Full Text] [Related]
6. Expression of soluble adenylyl cyclase in lentigo maligna: use of immunohistochemistry with anti-soluble adenylyl cyclase antibody (R21) in diagnosis of lentigo maligna and assessment of margins.
Magro CM; Yang SE; Zippin JH; Zembowicz A
Arch Pathol Lab Med; 2012 Dec; 136(12):1558-64. PubMed ID: 23194049
[TBL] [Abstract][Full Text] [Related]
7. Contiguous lesions in lentigo maligna.
Dalton SR; Gardner TL; Libow LF; Elston DM
J Am Acad Dermatol; 2005 May; 52(5):859-62. PubMed ID: 15858478
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous occurrence of multiple melanoma in situ on sun-damaged skin (lentigo maligna), solar lentigo and labial melanosis: the value of dermoscopy in diagnosis.
Massi D; Nardini P; De Giorgi V; Carli P
J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):193-7. PubMed ID: 10642055
[TBL] [Abstract][Full Text] [Related]
9. Differential Expression of Cancer Testis Antigens on Lentigo Maligna and Lentigo Maligna Melanoma.
Tio D; Willemsen M; Krebbers G; Kasiem FR; Hoekzema R; van Doorn R; Bekkenk MW; Luiten RM
Am J Dermatopathol; 2020 Aug; 42(8):625-627. PubMed ID: 32701706
[TBL] [Abstract][Full Text] [Related]
10. Lentigo maligna: review of salient characteristics and management.
Kallini JR; Jain SK; Khachemoune A
Am J Clin Dermatol; 2013 Dec; 14(6):473-80. PubMed ID: 24019181
[TBL] [Abstract][Full Text] [Related]
11. Precursor lesion of malignant melanoma in xeroderma pigmentosum: reflections about solar lentigo as the precursor.
Hedblad MA; Borglund E
J Am Acad Dermatol; 1995 Apr; 32(4):680-2. PubMed ID: 7755744
[No Abstract] [Full Text] [Related]
12. Lentigo maligna and malignant melanoma in situ, lentigo maligna type.
Flotte TJ; Mihm MC
Hum Pathol; 1999 May; 30(5):533-6. PubMed ID: 10333223
[TBL] [Abstract][Full Text] [Related]
13. Identification of progenitor cancer stem cell in lentigo maligna melanoma.
Bongiorno MR; Doukaki S; Malleo F; Aricò M
Dermatol Ther; 2008 Jul; 21 Suppl 1():S1-5. PubMed ID: 18727808
[TBL] [Abstract][Full Text] [Related]
14. A collision tumor involving Basal cell carcinoma and lentigo maligna melanoma.
Belisle A; Gautier MS; Ghozali F; Plantier F; Wechsler J
Am J Dermatopathol; 2005 Aug; 27(4):319-21. PubMed ID: 16121053
[TBL] [Abstract][Full Text] [Related]
15. Precursors to skin cancer.
Sober AJ; Burstein JM
Cancer; 1995 Jan; 75(2 Suppl):645-50. PubMed ID: 7804989
[TBL] [Abstract][Full Text] [Related]
16. Clinical usefulness of reflectance confocal microscopy in the management of facial lentigo maligna melanoma.
Alarcón I; Carrera C; Puig S; Malvehy J
Actas Dermosifiliogr; 2014 Apr; 105(3):e13-7. PubMed ID: 24657027
[TBL] [Abstract][Full Text] [Related]
17. Collision tumor composed of Merkel cell carcinoma and lentigo maligna melanoma.
Forman SB; Vidmar DA; Ferringer TC
J Cutan Pathol; 2008 Feb; 35(2):203-6. PubMed ID: 18190446
[TBL] [Abstract][Full Text] [Related]
18. Lentigo maligna and superficial spreading melanoma are different in their in situ phase: an immunohistochemical study.
Auslender S; Barzilai A; Goldberg I; Kopolovic J; Trau H
Hum Pathol; 2002 Oct; 33(10):1001-5. PubMed ID: 12395373
[TBL] [Abstract][Full Text] [Related]
19. [Lentigo maligna: a diagnostic and therapeutic challenge].
Alcalay J
Harefuah; 2014 May; 153(5):259-60, 306, 305. PubMed ID: 25112116
[TBL] [Abstract][Full Text] [Related]
20. Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type.
Tannous ZS; Lerner LH; Duncan LM; Mihm MC; Flotte TJ
Hum Pathol; 2000 Jun; 31(6):705-8. PubMed ID: 10872664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
